http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78d8d0c97ddb56138d6f025aee39e205
Outgoing Links
Predicate | Object |
---|---|
family-name | Fukunaga |
name | Kohji Fukunaga |
given-name | Kohji |
organization-name | fukunaga@mail.pharm.tohoku.ac.jp Department of Pharmacology Tohoku University Graduate School of Pharmaceutical Sciences Sendai Japan Department of Pharmacology, Graduate School of Pharmaceutical Science, Tohoku University, Miyagi, Japan. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of Pharmacology Tohoku University Graduate School of Pharmaceutical Sciences Miyagi Japan Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan Department of Pharmacology, Tohoku University Graduate School of Pharmaceutical Sciences, Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan. Department of Pharmacology, Kumamoto University School of Medicine, Kumamoto, Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, 21st Century COE program CRESCENDO, Tohoku University, Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan. fukunaga@mail.pharm.tohoku.ac.jp Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University , 980-8578 Miyagi , Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University Department of Pharmacology, Kumamoto University School of Medicine, Honjo Kumamoto, Japan Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan; BRI Pharma Incorporated Sendai Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8574, Japan Departments of Physiology, and Clinical Pathology, Jichi Medical School, Minamikawachi-Machi, Tochigi 329-04, Japan; Laboratory for Neuronal Signal Transduction, Frontier Research Program, The Institute of Physical and Chemical Research, Wako-Shi, Saitama 351-01, Japan; Department of Pharmacology, Kumamoto University, Medical School, Kumamoto 860, Japan; and I Physiologisches Institut, Universität des Saarlandes, 66421 Homburg, Germany Department of Pharmacology Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan 6 From the Departments of Pharmacology (M.S.B., N.S., K.F.) and Synthetic Chemistry (M.S., Y.I.), Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; and Tohoku University 21st Century Center of Excellence Program “CRESCENDO” (K.F.), Sendai, Japan. Department of Pharmacology (T.Y., H.Y., K.F., E.M.), Kumamoto University School of Medicine, Kumamoto 860-0811 Department of CNS drug innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Electronic address: kfukunaga@tohoku.ac.jp. Department of Pharmacology Graduate School of Pharmaceutical Sciences, Tohoku University Sendai Japan *Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Department of Pharmacology, Graduate School of Pharmaceutical Sciences, and Tohoku University Graduate School of Pharmaceutical Sciences, Sendai 980-8578, Japan. Department of Pharmacology, Tohoku University Graduate School of Pharmaceutical sciences, Sendai, Japan BRI Pharma Incorporated Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University; 21st Century COE Program “Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation,” Tohoku University Department of Pharmacology Graduate School of Pharmaceutical Science Tohoku University Sendai Japan Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan. kfukunaga@m.tohoku.ac.jp. Department of CNS drug innovation, Graduate School of Pharmaceutical Sciences, Tohoku University Department of Pharmacology, Tohoku University Graduate School of Pharmaceutical Sciences Department of Pharmacology, Tohoku University Graduate School of Pharmaceutical Sciences, Japan. Department of Pharmacology, Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan Departments of Pharmaceutical Molecular Biology and Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan, Mitsubishi Kagaku Institute of Life Sciences, Minamiooya, Machida, Tokyo 194-8511, Japan, Laboratory of Medicinal Plant Science, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo 192-0392, Japan, and Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood... Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan; BRI Pharma Inc., Sendai 982-0804, Japan |
Incoming Links
Total number of triples: 405.